Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Mosapride and PPI on Acid Pocket in GERD
NCT02984930Unknown
- Sponsor
- Gangnam Severance Hospital
- Start
- Dec 2016
- Primary completion
- Jul 2018
- Modality
- Small Molecules
01
Overview
Randomised, single-blind trial in gastroesophageal reflux disease (GERD) comparing PPI + mosapride group with PPI + placebo group (2 arms). Primary endpoints: Size of the acid pocket at 4 weeks and Location of the acid pocket at 4 weeks. Status: unknown.
02
Drugs
mosapride
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT02984930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02984930.